K213955

Substantially Equivalent

0.9% Sodium Chloride Injection, USP, BD PosiFlush SafeScrub

Applicant: Becton, Dickinson and Company
Product code: QTI
Advisory panel: General Hospital
Date received: 2021-12-17
Decision date: 2022-07-16
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Franklin Lakes, NJ, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.